Injectable (Subcutaneous) GHK-Cu Subcutaneous injection delivers GHK-Cu systemically
In the future, priority should be given to advancing clinical trials, optimizing injectable formulations and administration regimens, addressing environmental and cost issues in production, and strengthening synergistic research with other preparations to enhance its application value and promote the leap from scientific research to clinical practice
However, in cases of severe nutrient malabsorption and pernicious anemia, injections are more efficient at correcting the deficiency
Preclinical toxicological data: Acute and subacute toxicity studies in rats did not reveal any mortality or significant organ toxicity, even at doses well above therapeutic doses (up to 100 times the effective dose)
Supports Healthy Red Blood Cell Production: Helps correct deficiencies involved in red blood cell formation, improving oxygen transport throughout the body
It is also associated with scalp and hair-focused studies, particularly in improving follicle activity and overall hair condition